S&P 500   4,554.89
DOW   35,416.98
QQQ   390.19
Alibaba is down more than 10% since earnings, now what?
[Investor Alert] Potential Breakthrough Medical Tech Investment Opportunity (Ad)
5 stocks for the Christmas wishlist: Hoping for a pullback
Teva Pharma is the way to play the re-rise of generic drugs
[Investor Alert] Potential Breakthrough Medical Tech Investment Opportunity (Ad)
Lemonade nears breakout, short interest surges, analysts bearish
ULTA stock is setting up to swing for the fences
[Investor Alert] Potential Breakthrough Medical Tech Investment Opportunity (Ad)
Li Auto smashes estimates proving EVs can be profitable
Get ready for Christmas shopping-sprees with these 2 winners
S&P 500   4,554.89
DOW   35,416.98
QQQ   390.19
Alibaba is down more than 10% since earnings, now what?
[Investor Alert] Potential Breakthrough Medical Tech Investment Opportunity (Ad)
5 stocks for the Christmas wishlist: Hoping for a pullback
Teva Pharma is the way to play the re-rise of generic drugs
[Investor Alert] Potential Breakthrough Medical Tech Investment Opportunity (Ad)
Lemonade nears breakout, short interest surges, analysts bearish
ULTA stock is setting up to swing for the fences
[Investor Alert] Potential Breakthrough Medical Tech Investment Opportunity (Ad)
Li Auto smashes estimates proving EVs can be profitable
Get ready for Christmas shopping-sprees with these 2 winners
S&P 500   4,554.89
DOW   35,416.98
QQQ   390.19
Alibaba is down more than 10% since earnings, now what?
[Investor Alert] Potential Breakthrough Medical Tech Investment Opportunity (Ad)
5 stocks for the Christmas wishlist: Hoping for a pullback
Teva Pharma is the way to play the re-rise of generic drugs
[Investor Alert] Potential Breakthrough Medical Tech Investment Opportunity (Ad)
Lemonade nears breakout, short interest surges, analysts bearish
ULTA stock is setting up to swing for the fences
[Investor Alert] Potential Breakthrough Medical Tech Investment Opportunity (Ad)
Li Auto smashes estimates proving EVs can be profitable
Get ready for Christmas shopping-sprees with these 2 winners
S&P 500   4,554.89
DOW   35,416.98
QQQ   390.19
Alibaba is down more than 10% since earnings, now what?
[Investor Alert] Potential Breakthrough Medical Tech Investment Opportunity (Ad)
5 stocks for the Christmas wishlist: Hoping for a pullback
Teva Pharma is the way to play the re-rise of generic drugs
[Investor Alert] Potential Breakthrough Medical Tech Investment Opportunity (Ad)
Lemonade nears breakout, short interest surges, analysts bearish
ULTA stock is setting up to swing for the fences
[Investor Alert] Potential Breakthrough Medical Tech Investment Opportunity (Ad)
Li Auto smashes estimates proving EVs can be profitable
Get ready for Christmas shopping-sprees with these 2 winners

Privia Health Group Stock Price, News & Analysis (NASDAQ:PRVA)

$22.10
+0.16 (+0.73%)
(As of 11/28/2023 ET)
Compare
Today's Range
$21.57
$22.25
50-Day Range
$20.42
$23.65
52-Week Range
$19.68
$30.15
Volume
485,460 shs
Average Volume
1.13 million shs
Market Capitalization
$2.61 billion
P/E Ratio
71.29
Dividend Yield
N/A
Price Target
$34.64

Privia Health Group MarketRank™ Stock Analysis

Analyst Rating
Buy
3.00 Rating Score
Upside/​Downside
56.7% Upside
$34.64 Price Target
Short Interest
Bearish
6.63% of Float Sold Short
Dividend Strength
N/A
Sustainability
N/A
News Sentiment
0.93mentions of Privia Health Group in the last 14 days
Based on 2 Articles This Week
Insider Trading
Selling Shares
$1.32 M Sold Last Quarter
Proj. Earnings Growth
45.45%
From $0.22 to $0.32 Per Share

Overall MarketRank

MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.

2.74 out of 5 stars

Medical Sector

165th out of 949 stocks

Health Services Industry

3rd out of 12 stocks


PRVA stock logo

About Privia Health Group Stock (NASDAQ:PRVA)

Privia Health Group, Inc. operates as a national physician-enablement company in the United States. The company collaborates with medical groups, health plans, and health systems to optimize physician practices, enhance patient experiences, and reward doctors for delivering care in-person and virtual settings. It offers technology and population health tools to enhance independent providers' workflows; management services organization that enable providers to focus on their patients by reducing administrative work; single-TIN medical group that facilitates payer negotiation, clinical integration and alignment of financial incentives; accountable care organization, which engage patients, reduce inappropriate utilization, and enhance coordination and patient quality metrics to drive value-based care; and network for purchasers and payers that enable providers to connect with new patient populations and create custom contracts. The company was founded in 2007 and is headquartered in Arlington, Virginia. Privia Health Group, Inc. is a subsidiary of Brighton Health Group Holdings, LLC.

PRVA Stock Price History

PRVA Stock News Headlines

Privia Health Group Inc
[Investor Alert] Potential Breakthrough Medical Tech Investment Opportunity
Autonomix has patented technology that can detect and target nerve signals at an accuracy never seen before, a $100B opportunity. Now the team with almost $600M in exits is planning to list Autonomix on the Nasdaq. And you can invest in Autonomix ahead of their intended Nasdaq listing.* *Disclosure: This is a paid advertisement for Autonomix’s Regulation A+ Offering. Please read the offering circular at invest.autonomix.com
Q3 2023 Privia Health Group Inc Earnings Call
Privia Health (PRVA) Q3 Earnings Miss Estimates
[Investor Alert] Potential Breakthrough Medical Tech Investment Opportunity
Autonomix has patented technology that can detect and target nerve signals at an accuracy never seen before, a $100B opportunity. Now the team with almost $600M in exits is planning to list Autonomix on the Nasdaq. And you can invest in Autonomix ahead of their intended Nasdaq listing.* *Disclosure: This is a paid advertisement for Autonomix’s Regulation A+ Offering. Please read the offering circular at invest.autonomix.com
4 Analysts Have This to Say About Privia Health Gr
Privia Health to Enter Washington State
See More Headlines
Receive PRVA Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Privia Health Group and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Last Earnings
11/03/2023
Today
11/28/2023
Fiscal Year End
12/31/2023
Next Earnings (Estimated)
2/27/2024

Industry, Sector and Symbol

Industry
Health services
Sub-Industry
N/A
Sector
Medical
Current Symbol
NASDAQ:PRVA
Fax
N/A
Employees
964
Year Founded
N/A

Price Target and Rating

Average Stock Price Target
$34.64
High Stock Price Target
$41.00
Low Stock Price Target
$26.00
Potential Upside/Downside
+56.7%
Consensus Rating
Buy
Rating Score (0-4)
3.00
Research Coverage
9 Analysts

Profitability

Net Income
$-8,590,000.00
Pretax Margin
1.78%

Debt

Sales & Book Value

Annual Sales
$1.36 billion
Book Value
$4.53 per share

Miscellaneous

Free Float
65,171,000
Market Cap
$2.61 billion
Optionable
Not Optionable
Beta
0.87
A Guide To High-Short-Interest Stocks Cover

MarketBeat's analysts have just released their top five short plays for December 2023. Learn which stocks have the most short interest and how to trade them. Click the link below to see which companies made the list.

Get This Free Report














PRVA Stock Analysis - Frequently Asked Questions

Should I buy or sell Privia Health Group stock right now?

9 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Privia Health Group in the last year. There are currently 9 buy ratings for the stock. The consensus among Wall Street analysts is that investors should "buy" PRVA shares.
View PRVA analyst ratings
or view top-rated stocks.

What is Privia Health Group's stock price target for 2024?

9 equities research analysts have issued 1-year price objectives for Privia Health Group's stock. Their PRVA share price targets range from $26.00 to $41.00. On average, they predict the company's stock price to reach $34.64 in the next year. This suggests a possible upside of 56.7% from the stock's current price.
View analysts price targets for PRVA
or view top-rated stocks among Wall Street analysts.

How have PRVA shares performed in 2023?

Privia Health Group's stock was trading at $22.71 at the start of the year. Since then, PRVA stock has decreased by 2.7% and is now trading at $22.10.
View the best growth stocks for 2023 here
.

When is Privia Health Group's next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Tuesday, February 27th 2024.
View our PRVA earnings forecast
.

How were Privia Health Group's earnings last quarter?

Privia Health Group, Inc. (NASDAQ:PRVA) released its quarterly earnings results on Friday, November, 3rd. The company reported $0.05 EPS for the quarter, hitting the consensus estimate of $0.05. The business earned $417.30 million during the quarter, compared to the consensus estimate of $410.51 million. Privia Health Group had a trailing twelve-month return on equity of 6.80% and a net margin of 2.40%. The firm's revenue for the quarter was up 21.7% on a year-over-year basis. During the same quarter in the prior year, the company posted $0.01 earnings per share.

When did Privia Health Group IPO?

(PRVA) raised $351 million in an initial public offering (IPO) on Thursday, April 29th 2021. The company issued 19,500,000 shares at $17.00-$19.00 per share. Goldman Sachs, J.P. Morgan, Credit Suisse, Piper Sandler and William Blair served as the underwriters for the IPO and Canaccord Genuity, Truist Securities, R. Seelaus & Co. and Siebert Williams Shank were co-managers.

Who are Privia Health Group's major shareholders?

Privia Health Group's stock is owned by a number of retail and institutional investors. Top institutional shareholders include FMR LLC (12.09%), Bank of New York Mellon Corp (3.44%), Riverbridge Partners LLC (3.40%), Principal Financial Group Inc. (2.99%), Invesco Ltd. (1.46%) and Avidity Partners Management LP (1.31%). Insiders that own company stock include Advisors LLC Mbd, David Mountcastle, Jeffrey B Butler, Jeffrey Daniel Bernstein, Matthew Shawn Morris, Pamplona Capital Partners Iii,, Parth Mehrotra, Thomas Bartrum and William M Sullivan.
View institutional ownership trends
.

How do I buy shares of Privia Health Group?

Shares of PRVA stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

This page (NASDAQ:PRVA) was last updated on 11/29/2023 by MarketBeat.com Staff

My Account -